Sarepta Therapeutics

AMONDYS-45

Manufacturer:

Sarepta Therapeutics

Amondys-45 HCPCS:

J1426

HCPCS Code Descriptor:

Injection, casimersen, 10 mg

Category:

J Code

Amondys-45 NDCs:

60923-0227-02

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Amondys-45:

AMONDYS-45 is a Genetic Disorder drug manufactured by Sarepta Therapeutics and administered via the Intravenous route of administration. The J Code: J1426 is aligned to the drug AMONDYS-45.

ACCESS PRICING AND MORE BY REGISTERING

J1426 Added Date:

October 1, 2021

J1426 Effective Date:

October 1, 2021

J1426 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Amondys-45 billing and coding information.
Amondys-45 patient assistance information can be found through SareptAssist at the URL: https://www.sarepta.com/sareptassist
AMONDYS-45 prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for AMONDYS-45. Please check back in a few weeks.